ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,017 | -59.0% | 410 | -45.6% | 0.00% | -66.7% |
| Q2 2023 | $26,852 | +24.1% | 753 | -11.6% | 0.00% | +50.0% |
| Q1 2023 | $21,641 | -45.7% | 852 | -13.2% | 0.00% | -60.0% |
| Q4 2022 | $39,830 | +148.9% | 982 | +105.9% | 0.01% | +150.0% |
| Q3 2022 | $16,000 | +128.6% | 477 | +136.1% | 0.00% | +100.0% |
| Q2 2022 | $7,000 | -30.0% | 202 | -5.6% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | -66.7% | 214 | -52.4% | 0.00% | -75.0% |
| Q4 2021 | $30,000 | +57.9% | 450 | +46.6% | 0.00% | +33.3% |
| Q3 2021 | $19,000 | -24.0% | 307 | +3.0% | 0.00% | -25.0% |
| Q2 2021 | $25,000 | -7.4% | 298 | -27.7% | 0.00% | 0.0% |
| Q1 2021 | $27,000 | -12.9% | 412 | +2.0% | 0.00% | -33.3% |
| Q4 2020 | $31,000 | +181.8% | 404 | +59.1% | 0.01% | +200.0% |
| Q3 2020 | $11,000 | +10.0% | 254 | +10.4% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | +900.0% | 230 | +434.9% | 0.00% | – |
| Q1 2020 | $1,000 | -95.2% | 43 | -88.5% | 0.00% | -100.0% |
| Q4 2019 | $21,000 | +950.0% | 374 | +249.5% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 107 | +91.1% | 0.00% | – |
| Q2 2019 | $1,000 | – | 56 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |